Showing results (121-130 of 214) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|November 15, 1993
Multicenter evaluation of commercially available methods for the immunological determination of plasminogen activator inhibitor-1 (PAI-1)P J Declerck, H Moreau, J Jespersen, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|November 19, 2005
Lack of hepatic metabolism of C-telopeptides of type I collagenP Qvist, K R Petersen, J Jespersen, et al.
Clinical and Vaccine Immunology : CVI|April 30, 2010
Evaluation of the Bio-Rad BioPlex 2200 syphilis multiplex flow immunoassay for the detection of IgM- and IgG-class antitreponemal antibodiesE Gomez, D J Jespersen, J A Harring, et al.
Coronary Artery Disease|May 1, 1997
Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator-plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarctionO D Pedersen, J Gram, X Jeunemaitre, et al.
Scandinavian Journal of Urology and Nephrology|January 1, 1985
Subcutaneous heparin in the treatment of interstitial cystitisG Lose, J Jespersen, B Frandsen, et al.
Thrombosis Research|August 15, 1985
Plasma histidine-rich glycoprotein and plasminogen in patients with liver diseaseJ Gram, J Jespersen, S Ingeberg, et al.
Coronary Artery Disease|July 1, 1994
Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diureticsO D Pedersen, J Gram, H Bagger, et al.
European Heart Journal|June 1, 1993
Depression of factor XII-dependent fibrinolytic activity in survivors of acute myocardial infarction at risk of reinfarctionO D Pedersen, S Munkvad, J Gram, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|June 12, 2003
Hormone replacement therapy and hypercoagulability. Results from the Prospective Collaborative Danish Climacteric StudyJ J Sidelmann, J Jespersen, L F Andersen, et al.
Diabetes Care|October 7, 1997
No effect of unfractioned or low molecular weight heparin treatment on markers of vascular wall and hemostatic function in incipient diabetic nephropathyB Myrup, T Jensen, J Gram, et al.
Pageof 22